Sign in

CIK 0001937993 · <br>Emerging growth company

Cadrenal Therapeutics, Inc.

Sign in to watch
Ticker
CVKD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880860746
Phone
904-300-0701
Business address
822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
  1. 4 Planned sale Chief Financial Officer sold 3,493 shares at an average $14.03 ($49,011)
  2. 4 Planned sale CEO and Chairman sold 3,600 shares at an average $14.09 ($50,706)
  3. 4 Planned sale Chief Financial Officer sold 107 shares at $13.99 ($1,497)
  4. 4 Planned sale CEO and Chairman sold 500 shares at $14.13 ($7,065)
  5. 4 Planned sale Chief Financial Officer sold 1,800 shares at an average $13.99 ($25,183)
  6. 4 Planned sale CEO and Chairman sold 1,300 shares at $14.01 ($18,213)
  7. 4 Planned sale Chief Financial Officer sold 12,400 shares at an average $14.05 ($174,175)
  8. 4 Planned sale CEO and Chairman sold 9,371 shares at an average $14.06 ($131,779)
  9. 4 Planned sale Chief Financial Officer sold 2,000 shares at an average $14.00 ($27,992)
  10. 4 Planned sale CEO and Chairman sold 5,029 shares at $13.99 ($70,356)
  11. 4/A Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 4 · 69 filings